These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8306420)

  • 1. A phase II study of pirarubicin in patients with advanced recurrent head and neck squamous cell carcinoma.
    De Mulder PH; Cappelaere P; Cognetti F; Verweij J; Schornagel JH; Vermorken JB; Kirkpatrick A; Lefebvre JL
    Cancer Chemother Pharmacol; 1994; 33(5):438-40. PubMed ID: 8306420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinoma.
    Sridhar KS; Hussein AM; Benedetto P; Ardalan B; Savaraj N; Richman SP
    Cancer; 1992 Sep; 70(6):1591-7. PubMed ID: 1516010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of esorubicin (4'-deoxydoxorubicin) in locally advanced or metastatic head and neck carcinoma.
    Frustaci S; Gasparini G; Veronesi A; Tirelli U; Pacciarini MA; Crivellari D; Zagonel V; Monfardini S
    Invest New Drugs; 1987; 5(3):307-9. PubMed ID: 3667167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II clinical trial of 4'-O-tetrahydropyranyl-adriamycin (THP-adriamycin) in recurrent squamous cell carcinoma of the head and neck.
    Shin DM; Kramer AM; Dimery IW; Raber MN; Ewer M; Hong WK
    Invest New Drugs; 1991 Feb; 9(1):89-91. PubMed ID: 2026488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional effects of pegylated liposomal doxorubicin (Caelyx) in irradiated area: a phase I-II study in patients with recurrent squamous cell carcinoma of the head and neck.
    Faivre S; Alsabe H; Djafari L; Janot F; Julieron M; Domenge C; Djazouli K; Armand JP; Luboinski B; Raymond E
    Eur J Cancer; 2004 Jul; 40(10):1517-21. PubMed ID: 15196535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of pirarubicin in epidermoid carcinoma of the head and neck.
    Cappelaere P; Guiochet N; Chauvergne J; Bastit P; Armand JP; Lentz MA; Van Glabbeke M; Herait P; Fumoleau P
    Eur J Cancer; 1992; 28(2-3):484-5. PubMed ID: 1591069
    [No Abstract]   [Full Text] [Related]  

  • 8. Aclacinomycin. Phase II evaluation in advanced squamous carcinoma of the head and neck.
    Kish JA; Al-Sarraf M
    Am J Clin Oncol; 1984 Oct; 7(5):535-7. PubMed ID: 6507374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
    Soulières D; Faivre S; Mesía R; Remenár É; Li SH; Karpenko A; Dechaphunkul A; Ochsenreither S; Kiss LA; Lin JC; Nagarkar R; Tamás L; Kim SB; Erfán J; Alyasova A; Kasper S; Barone C; Turri S; Chakravartty A; Chol M; Aimone P; Hirawat S; Licitra L
    Lancet Oncol; 2017 Mar; 18(3):323-335. PubMed ID: 28131786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of pirarubicin in the treatment of advanced bladder cancer.
    Mahjoubi M; Kattan J; Ghosn M; Droz JP; Philippot I; Herait P
    Invest New Drugs; 1992 Nov; 10(4):317-21. PubMed ID: 1487407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer.
    Pfister DG; Bajorin D; Motzer RJ; Scher H; Louison C; Harrison L; Shah J; Strong E; Bosl G
    Invest New Drugs; 1993 Feb; 11(1):53-6. PubMed ID: 8349436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Rose PG; Blessing JA; Lele S; Abulafia O
    Gynecol Oncol; 2006 Aug; 102(2):210-3. PubMed ID: 16478630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
    Machiels JP; Haddad RI; Fayette J; Licitra LF; Tahara M; Vermorken JB; Clement PM; Gauler T; Cupissol D; Grau JJ; Guigay J; Caponigro F; de Castro G; de Souza Viana L; Keilholz U; Del Campo JM; Cong XJ; Ehrnrooth E; Cohen EE;
    Lancet Oncol; 2015 May; 16(5):583-94. PubMed ID: 25892145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of pirarubicin in the treatment of advanced pancreatic cancer.
    Mahjoubi M; Rougier P; Oliviera J; Herait P; Tigaud JM; Droz JP
    Cancer Invest; 1994; 12(4):403-5. PubMed ID: 8032961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group.
    Verweij J; Wanders J; Gil T; Schöffski P; Catimel G; te Velde A; de Mulder PH
    Br J Cancer; 1996 Feb; 73(3):400-2. PubMed ID: 8562350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Sandler S; Bonomi P; Taylor B; Showel J; Slayton R; Lerner H
    Cancer Treat Rep; 1984 Sep; 68(9):1163-5. PubMed ID: 6541095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).
    Galetta D; Giotta F; Rosati G; Gebbia V; Manzione L; Di Bisceglie M; Borsellino N; Colucci G
    Anticancer Res; 2005; 25(6C):4445-9. PubMed ID: 16334124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II study with pirarubicin in pretreated progressive head-neck neoplasms].
    Iro H; König HJ
    Laryngorhinootologie; 1990 Mar; 69(3):131-4. PubMed ID: 1692705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.